Participant flow25

How many started, completed or left each group, period by period.

1 to 20 of 25

Period	Milestone	Group	Participants
Period 1	STARTED	All Participants	20
Period 1	Infliximab	All Participants	7
Period 1	Rituximab	All Participants	7
Period 1	Tocilizumab	All Participants	3
Period 1	Placebo	All Participants	1
Period 1	Not Randomised	All Participants	2
Period 1	COMPLETED	All Participants	15
Period 1	NOT COMPLETED	All Participants	5
Period 2	STARTED	All Participants	10
Period 2	Infliximab	All Participants	4
Period 2	Rituximab	All Participants	2
Period 2	Tocilizumab	All Participants	4
Period 2	Placebo	All Participants	0
Period 2	COMPLETED	All Participants	9
Period 2	NOT COMPLETED	All Participants	1
Period 3	STARTED	All Participants	1
Period 3	Infliximab	All Participants	1
Period 3	Rituximab	All Participants	0
Period 3	Tocilizumab	All Participants	0
Period 3	Placebo	All Participants	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05168475/flow